NCT06400121View on ClinicalTrials.gov

Apimostinel + Automated Neurocognitive Training for Depression

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 28, 2024

Primary Completion Date

March 1, 2029

Study Completion Date

December 1, 2029

Conditions
Depression
Interventions
DRUG

Apimostinel Infusion, Intravenous

Single injection of Apimostinel (10mg)

BEHAVIORAL

Cognitive Training

8 sessions of digital active training

BEHAVIORAL

Sham Training

8 sessions of digital sham training

DRUG

Isotonic Solution, Intravenous

Single injection of placebo

Trial Locations (1)

15213

RECRUITING

Western Psychiatric Institute and Clinic, Pittsburgh

All Listed Sponsors
collaborator

Syndeio Biosciences, Inc

INDUSTRY

lead

Rebecca Price

OTHER